Ankylose This! Living with Ankylosing Spondylitis

Monday, August 03, 2009

Generic versions of biologics?

While there are generic equivalents of many chemically based drugs that cost patients a fraction of the brand-name cost (thanks, I suppose, to the original drug patents expiring), this is not the case for the high-cost biologics -- like Enbrel, Humira and Remicade -- that many of us are turning to for relief. That high cost is raising the question of how long brand-name biologics can be exempt from market competition from "biosimilar" or "biogeneric" drugs -- especially in the U.S., where the high cost of drugs and cost containment are a crucial part of the health coverage debate. The Chicago Tribune has the story.

Labels: , ,

Comments on this post

Post a Comment

Links to this post

Create a Link

江西快3预测 中图库好运彩97654 香港赛马会最新消息 13835平特一肖 最快最准 北京pk10计划 温州麻将规则 43592王中王精准六肖 爱玩捕鱼红包版的下载 22选5中奖多少奖金 开户买股票 浙体育彩票6十1开奖号